Michael Barbella, Managing Editor10.10.23
Perosphere Technologies has appointed Michelle Brennan to its Board of Directors. With deep understanding of and fluency in the healthcare sector, Brennan will play a pivotal role in guiding Perosphere’s strategic direction and supporting its mission to develop and commercialize innovative diagnostic tools.
As former company group chair of Medical Devices at Johnson & Johnson, Brennan was instrumental in driving initiatives that prioritize patient safety, comfort, and well-being while growing the division. Brennan is also the former president of Enterprise Standards & Productivity at Johnson & Johnson, where she sought to optimize systems, processes, and business models. Prior to that role, she was worldwide president for Ethicon Energy, also at Johnson & Johnson, where she installed a strategic leadership team to discover innovative opportunities and shape product development.
“With her extensive experience and expertise in medical devices, Michelle will be an exceptional addition to our Board of Directors,” Perosphere Technologies CEO Dr. Sasha Bakhru. “She will be a key part of the group of industry leaders that will advance the company’s growth strategy as we foster a new generation of tools supporting our mission to change the practice of medicine and transform patient care.”
Brennan brings more than three decades of demonstrated leadership in healthcare, including expertise in regulatory affairs, clinical trials, market access, and global commercialization directly related to medical devices. Brennan is currently on the boards of Cardinal Health and Masimo, and previously served on the board of COUPA Software until its recent acquisition. She is based in Spearfish, S.D.
“I am honored to have been invited to join Perosphere’s Board of Directors, as we share a deeply felt commitment to saving lives, time and money while elevating the standard of patient care,” Brennan stated. “Throughout my career, I have sought to drive progress that improves treatment, and the work that Perosphere is doing mirrors that commitment.”
Perosphere Technologies is a private medical technologies company focused on development and commercialization of its point-of-care Coagulometer, which informs diagnosis, treatment, and prevention through precision data. It is the only point-of-care diagnostic tool that effectively and swiftly tests clotting times across drug classes, including DOACs, according to the company. The fast diagnosis and related appropriate treatment decisions the PoC Coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. The PoC Coagulometer has a CE Mark in the EU but is not yet cleared in the United States.
As former company group chair of Medical Devices at Johnson & Johnson, Brennan was instrumental in driving initiatives that prioritize patient safety, comfort, and well-being while growing the division. Brennan is also the former president of Enterprise Standards & Productivity at Johnson & Johnson, where she sought to optimize systems, processes, and business models. Prior to that role, she was worldwide president for Ethicon Energy, also at Johnson & Johnson, where she installed a strategic leadership team to discover innovative opportunities and shape product development.
“With her extensive experience and expertise in medical devices, Michelle will be an exceptional addition to our Board of Directors,” Perosphere Technologies CEO Dr. Sasha Bakhru. “She will be a key part of the group of industry leaders that will advance the company’s growth strategy as we foster a new generation of tools supporting our mission to change the practice of medicine and transform patient care.”
Brennan brings more than three decades of demonstrated leadership in healthcare, including expertise in regulatory affairs, clinical trials, market access, and global commercialization directly related to medical devices. Brennan is currently on the boards of Cardinal Health and Masimo, and previously served on the board of COUPA Software until its recent acquisition. She is based in Spearfish, S.D.
“I am honored to have been invited to join Perosphere’s Board of Directors, as we share a deeply felt commitment to saving lives, time and money while elevating the standard of patient care,” Brennan stated. “Throughout my career, I have sought to drive progress that improves treatment, and the work that Perosphere is doing mirrors that commitment.”
Perosphere Technologies is a private medical technologies company focused on development and commercialization of its point-of-care Coagulometer, which informs diagnosis, treatment, and prevention through precision data. It is the only point-of-care diagnostic tool that effectively and swiftly tests clotting times across drug classes, including DOACs, according to the company. The fast diagnosis and related appropriate treatment decisions the PoC Coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. The PoC Coagulometer has a CE Mark in the EU but is not yet cleared in the United States.